Round

回合

marks major expansion of FIZE Medical's strategic relationship

标志着 FIZE Medical 战略关系的重大扩展

with Asahi Kasei Medical

与旭化成医疗

, including distribution

，包括分发

in Japan and Europe, and accelerates development of its next-generation predictive, AI-guided fluid management

在日本和欧洲，并加速开发其下一代基于人工智能指导的预测性流体管理技术

platform

平台

JERICHO, N.Y.

纽约州杰里科

,

，

Sept. 17, 2026

2026年9月17日

/PRNewswire/ --

/美通社/ --

FIZE Medical

FIZE医疗

, a leader in smart fluid management solutions for critically ill patients, today announced the first close of its Series B financing round, co-led by

，作为面向危重患者的智能液体管理解决方案的领导者，今日宣布完成其B轮融资的首次交割，该轮融资由

Asahi Kasei Medical

旭化成医疗

and

和

Rapha Capital Management

拉法资本管理公司

, making significant headway towards the company's $20 million financing target.

，朝着公司2000万美元的融资目标取得了重大进展。

The financing comes at a pivotal point in FIZE Medical's growth, as the company expands its commercial footprint and advances its next-generation FIZE Optima platform toward predictive, AI-guided clinical decision support.

此次融资正值菲泽医疗（FIZE Medical）发展的关键阶段，公司正不断扩大其商业布局，并推动其下一代FIZE Optima平台向具备预测能力、由人工智能引导的临床决策支持方向迈进。

The FIZE Medical Team. Photo: Nir Antman

FIZE 医疗团队。照片：Nir Antman

FIZE kUO® Platform

FIZE kUO® 平台